Literature DB >> 9973984

Failures after operation for skeletal metastatic lesions of long bones.

R Wedin1, H C Bauer, P Wersäll.   

Abstract

This study was based on 192 patients treated surgically for 228 metastatic lesions of the long bones from 1986 through 1995. The survival rate was 0.3 at 1 year after surgery. The surgical treatment consisted of resection and reconstruction of the involved bone (18), intralesional curettage (133), or stabilization only (77). Reconstruction was achieved by an endoprosthesis in 54 cases, by an osteosynthetic device in 162, by cement only in 10. In two cases no reconstruction was performed. The local failure rate was 11% and the median time to failure was 8 months. Local failure was most frequent in patients with kidney cancer (24%) and in diaphyseal and distal femoral lesions (20%). Among 162 operations involving osteosynthetic devices, 22 (14%) were failures as compared with one of 54 (2%) endoprostheses. Sixty percent of the patients received preoperative or postoperative radiotherapy. Five of the six patients who had surgery for local tumor progression had not received radiotherapy. Eight of 10 nonunions and all five patients who developed a stress fracture had been treated with radiotherapy. It is concluded that endoprosthetic reconstructions are preferable to osteosynthetic devices. The skeletal complications associated with radiotherapy may be circumvented by the use of endoprostheses.

Entities:  

Mesh:

Year:  1999        PMID: 9973984

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  38 in total

1.  Subtrochanteric metastatic lesions treated with the long gamma nail.

Authors:  S R Samsani; V Panikkar; D Georgiannos; D Calthorpe
Journal:  Int Orthop       Date:  2003-06-11       Impact factor: 3.075

2.  Treatment results of pathological fractures of the long bones: a retrospective analysis of 88 patients.

Authors:  Kambiz Sarahrudi; Katherina Hora; Thomas Heinz; Steven Millington; Vilmos Vécsei
Journal:  Int Orthop       Date:  2006-08-30       Impact factor: 3.075

3.  Metastatic disease of the long bones: a review of the health care burden in a major trauma centre.

Authors:  Michael Kelly; Mitchell Lee; Paul Clarkson; Peter J O'Brien
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

4.  What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur?

Authors:  Joel R Peterson; Alexander P Decilveo; Ian T O'Connor; Ivan Golub; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

5.  What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Authors:  Julie J Willeumier; Mustafa Kaynak; Peer van der Zwaal; Sven A G Meylaerts; Nina M C Mathijssen; Paul C Jutte; Panagiotis Tsagozis; Rikard Wedin; Michiel A J van de Sande; Marta Fiocco; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

6.  CORR Insights®: Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing?

Authors:  Benjamin J Miller
Journal:  Clin Orthop Relat Res       Date:  2016-11-10       Impact factor: 4.176

Review 7.  [Prognosis-adapted surgical management of bone metastases].

Authors:  S Utzschneider; P Weber; A Fottner; B Wegener; V Jansson; H R Dürr
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

8.  [Surgical treatment of pathologic fractures of the humerus and femur].

Authors:  G Gruber; M Zacherl; A Leithner; C Giessauf; M Glehr; H Clar; R Windhager
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

9.  Minimally invasive treatment of pathological fractures of the humeral shaft.

Authors:  Onder Ofluoglu; Bulent Erol; Zerrin Ozgen; Muzaffer Yildiz
Journal:  Int Orthop       Date:  2008-04-03       Impact factor: 3.075

10.  Proximal humerus reconstructions for tumors.

Authors:  Benjamin K Potter; Sheila C Adams; J David Pitcher; Theodore I Malinin; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2008-09-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.